Training: Dental Research, Bioengineering.
Postdoctoral: TGF-beta, wound healing, regeneration, radiation biology, light biology, stem cells, biomaterial, Lasers.
Current: Clinical translational research and Molecular mechanisms.
Positions: President, NAALT; Chair SPIE, Chair ALD; Chair ASLMS.
Interests: Signal Transduction, Lasers, Biological regulation.
Jürgen C. Becker is Professor of Dermatology at the Meduni Graz, Austria. He received his MD from the Medical School Hanover and his PhD in Immunology from the Open University, London. His research interests include the characterisation of cellular und humoral immune responses in the setting of neoplastic diseases; genetic and epigenetic aberrations in cancer; as well as therapeutic interventions to treat cancer.
Regents Professor of Chemistry and Biochemistry at the University of Arizona. Professor of Neuroscience Recently inducted into the ACS Hall of Fame and 2011 ACS Goodman Award for Scientific Excellence and Mentorship.
Professor of Cutaneous Medicine, University of Manchester and Professor of Dermatology and Experimental Dermatology, University of Luebeck. Editor, Epxerimental Dermatology.
Mauro Picardo, Director of the Cutaneous Physiopathology Laboratory and Metabolomic Center San Gallicano Dermatological Institute in Rome. Chairman Integrated Center of Metabolomic Research, ESDR ESPCR EADV board member, chairman Vitiligo European Task Force and EADV Pigmentary disorders group . President of the International Federation of Pigment Cell Societies. Author of more than 250 publications and of more than 30 chapters in different books.
Dr. Tarl Prow is the Deputy Director of the Dermatology Research Centre within the School of Medicine and heads a group of 10 researchers focused on micromedical devices for dermatology and nanomedicine. He is a multidisciplinary researcher with internationally recognized expertise in the fields of micro-medical device development, nanodermatology, topical drug delivery and non-invasive imaging.
Research focus on tumorimmunology and tumorbiology of skin cancer especially melanoma and merkel cell carcinoma. PhD and Post-Doc at medical university hospital Wuerzburg. Now Associate Professor at Medical University Graz, Austria.
As academic dermatologist from Austria I was appointed Inaugural Chair in Dermatology by The University of Queensland in 2007. Recently, I have been awarded a National Health Medical Research Council (NHMRC) Practitioner Fellowship in Australia. My research expertise lies in dermatooncology, dermatopathology, and clinico-molecular correlation of neoplastic skin lesions. In the last years I have been fascinated by Open Access Teledermatology with the vision of “Melanoma Diagnosis by One Click”.
Desmond J. Tobin is Professor of Cell Biology and Director of the Centre for Skin Sciences at University of Bradford. He holds a BSc from the National University of Ireland (Maynooth), a PhD from the University of London (St. John’s Institute of Dermatology) and post-doctoral training from New York University Medical School. Over the past 20 years he has researched in basic and applied skin/hair sciences, with a particular focus on the biology of human melanocytes/ pigmentation and hair growth disorders especially those with an immune basis.
He was the first to identify antibodies to hair follicle-specific antigens in patients with acute alopecia areata, and also the first to establish melanocytes from the human hair follicles in long-term culture. He has identified a self-similarity of the POMC peptide system in the human hair follicle pigmentary unit, how pigmentation can be regulated by CRF and POMC peptides (incl. beta endorphin), and more recently by bone morphogenetic proteins. He has revealed an unexpected role for filopodia in melanin transfer under the influence of myoxin-X and cdc42. Des Tobin is a Fellow of Royal College of Pathologists, Fellow of the Royal Society of Biology, and Fellow of the Institute of Trichologists (Vice-President). He is a member of the Healthcare Technology Cooperative in Wound Prevention and Treatment. Des serves(ed) on several editorial boards, and has published over 140 publications, incl. 3 books. His H-Index is currently 50.